Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric multiple-dose apixaban PK/PD study in children with an indwelling central venous catheter
NL-OMON36556Withdrawn
- Sponsor
- Bristol Myers Squibb
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of apixaban in venous thromboembolism (VTE) and catheter-related thrombosis (CRT), sponsored by Bristol Myers Squibb. Primary endpoint: Pharmacokinetic measures. Planned start Jul 2011; status: withdrawn.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)catheter-related thrombosis (CRT)
Beyond the preview
Go deeper on NL-OMON36556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36556.